Using its LysoSeeker drug discovery platform, Samsara is developing autophagy-directed therapies to fight currently incurable neurodegenerative diseases such as Parkinson’s and Amytotrophic Lateral Sclerosis (ALS).
Using its LysoSeeker drug discovery platform, Samsara is developing autophagy-directed therapies to fight currently incurable neurodegenerative diseases such as Parkinson’s and Amytotrophic Lateral Sclerosis (ALS).
